Spasenija Savic

4.1k total citations · 1 hit paper
49 papers, 2.5k citations indexed

About

Spasenija Savic is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Spasenija Savic has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Spasenija Savic's work include Lung Cancer Treatments and Mutations (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Spasenija Savic is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Spasenija Savic collaborates with scholars based in Switzerland, Germany and Greece. Spasenija Savic's co-authors include Lukas Bubendorf, Alexandar Tzankov, Gieri Cathomas, Hans Pargger, Kirsten D. Mertz, Markus Tolnay, Jasmin D. Haslbauer, Nikolaus Deigendesch, Stefano Bassetti and Stephan Frank and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Spasenija Savic

48 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

2020 834 citations Thomas Menter, Jasmin D. Haslbauer et al. Histopathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Spasenija Savic Switzerland	26	1.0k	922	661	524	386	49	2.5k
Simona Coco Italy	27	998 1.0×	797 0.9×	330 0.5×	863 1.6×	717 1.9×	102	2.6k
Qingzhu Jia China	21	971 0.9×	551 0.6×	658 1.0×	628 1.2×	418 1.1×	55	2.4k
Giovanni Ponti Italy	28	1.3k 1.3×	349 0.4×	508 0.8×	734 1.4×	644 1.7×	105	3.1k
Da Xu China	24	609 0.6×	401 0.4×	300 0.5×	839 1.6×	592 1.5×	71	2.1k
Yohei Hisada United States	28	569 0.6×	334 0.4×	360 0.5×	1.1k 2.0×	213 0.6×	70	2.9k
Marie Christine Aubry United States	29	1.3k 1.2×	1.4k 1.5×	87 0.1×	598 1.1×	368 1.0×	102	2.9k
Yusuke Okuma Japan	24	1.6k 1.5×	936 1.0×	98 0.1×	549 1.0×	273 0.7×	186	2.5k
Camillo Ribi Switzerland	22	1.4k 1.4×	996 1.1×	211 0.3×	366 0.7×	75 0.2×	111	3.3k

Countries citing papers authored by Spasenija Savic

Since Specialization

Citations

This map shows the geographic impact of Spasenija Savic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spasenija Savic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spasenija Savic more than expected).

Fields of papers citing papers by Spasenija Savic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spasenija Savic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spasenija Savic. The network helps show where Spasenija Savic may publish in the future.

Co-authorship network of co-authors of Spasenija Savic

This figure shows the co-authorship network connecting the top 25 collaborators of Spasenija Savic. A scholar is included among the top collaborators of Spasenija Savic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spasenija Savic. Spasenija Savic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Savic, Spasenija, Lars Knudsen, Danny Jonigk, et al.. (2024). The use of cultured human alveolar basal cells to mimic honeycomb formation in idiopathic pulmonary fibrosis. Respiratory Research. 25(1). 26–26. 4 indexed citations

Menter, Thomas, Jasmin D. Haslbauer, Ronny Nienhold, et al.. (2020). Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 77(2). 198–209. 834 indexed citations breakdown →

König, David, Urs R. Meier, Bernd Klaeser, Spasenija Savic, & Miklos Pless. (2020). Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC. Case Reports in Oncology. 13(2). 729–732. 1 indexed citations

Hostettler, Katrin, Spasenija Savic, Lukas Bubendorf, et al.. (2020). Diagnostic value of cryobiopsy in patients with interstitial lung diseases integrating bronchoalveolar lavage, radiologic and clinical data. 789–789. 1 indexed citations

Rothschild, Sacha I., Alfred Zippelius, E.I. Eboulet, et al.. (2020). SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC)—A multicenter single-arm phase II trial.. Journal of Clinical Oncology. 38(15_suppl). 9016–9016. 24 indexed citations

Sterlacci, William, Michael Fiegl, Mathias Gugger, et al.. (2017). MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLC. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(1). 49–55. 24 indexed citations

Berezowska, Sabina, José A. Galván, Rupert Langer, et al.. (2017). Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(3). 323–330. 20 indexed citations

Hostettler, Katrin, Amiq Gazdhar, Spasenija Savic, et al.. (2017). Multipotent mesenchymal stem cells in lung fibrosis. PLoS ONE. 12(8). e0181946–e0181946. 37 indexed citations

Savic, Spasenija & Lukas Bubendorf. (2016). Common Fluorescence In Situ Hybridization Applications in Cytology. Archives of Pathology & Laboratory Medicine. 140(12). 1323–1330. 27 indexed citations

10.

Müller, Philipp, Matthias Kreuzaler, Tarik A. Khan, et al.. (2015). Trastuzumab emtansine (T-DM1) renders HER2 ⁺ breast cancer highly susceptible to CTLA-4/PD-1 blockade. Science Translational Medicine. 7(315). 315ra188–315ra188. 269 indexed citations

11.

Savic, Spasenija, Joachim Diebold, Anne‐Katrin Zimmermann, et al.. (2015). Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended. Lung Cancer. 89(2). 104–109. 61 indexed citations

12.

Papakonstantinou, Eleni, George Karakiulakis, Spyros Batzios, et al.. (2015). Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection. Respiratory Research. 16(1). 78–78. 41 indexed citations

13.

Hostettler, Katrin, Jörg Halter, Sabine Gerull, et al.. (2013). Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. European Respiratory Journal. 43(1). 221–232. 5 indexed citations

14.

Savic, Spasenija, Beata Bode, Joachim Diebold, et al.. (2013). Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 Clone. Journal of Thoracic Oncology. 8(8). 1004–1011. 76 indexed citations

15.

Papakonstantinou, Eleni, Ioannis Klagas, George Karakiulakis, et al.. (2012). Steroids and β2-Agonists Regulate Hyaluronan Metabolism in Asthmatic Airway Smooth Muscle Cells. American Journal of Respiratory Cell and Molecular Biology. 47(6). 759–767. 24 indexed citations

16.

Savic, Spasenija & Lukas Bubendorf. (2012). Role of Fluorescence in situ Hybridization in Lung Cancer Cytology. Acta Cytologica. 56(6). 611–621. 39 indexed citations

17.

Baty, Florent, Sérgio Kaiser, M. Schumacher, et al.. (2009). Gene Profiling of Clinical Routine Biopsies and Prediction of Survival in Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 181(2). 181–188. 37 indexed citations

18.

Zellweger, Tobias, Inti Zlobec, Spasenija Savic, et al.. (2008). Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small‐volume or low‐grade prostate cancer. International Journal of Cancer. 124(9). 2116–2123. 67 indexed citations

19.

Glatz, Katharina, Spasenija Savic, Dieter Glatz, et al.. (2006). An online quiz uncovers limitations of morphology in equivocal lung cytology. Cancer. 108(6). 480–487. 9 indexed citations

20.

Glatz‐Krieger, Katharina, Mona Pache, Coya Tapia, et al.. (2006). Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(3). 328–333. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Coco Breakdown of academic impact, for papers by Qingzhu Jia Breakdown of academic impact, for papers by Giovanni Ponti Breakdown of academic impact, for papers by Da Xu Breakdown of academic impact, for papers by Yohei Hisada Breakdown of academic impact, for papers by Marie Christine Aubry Breakdown of academic impact, for papers by Yusuke Okuma Breakdown of academic impact, for papers by Camillo Ribi